Bo Qiu
Hebei Key Laboratory Of Clinical Pharmacy
Shijiazhuang, 050051, China
Shijiazhuang, 050051, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Effects of CYP1A2 genetic polymorphisms on the pharmacokinetics of pentoxifylline and its active metabolites.
Journal: BMC pharmacology & toxicology
Published: December 02, 2025
Effects of ABC transporter polymorphism on the pharmacokinetics of pentoxifylline and its active metabolites in healthy Chinese subjects.
Journal: European journal of clinical pharmacology
Published: September 12, 2025
Effect of High-Fat Food on the Pharmacokinetics and Safety of Amlodipine/Benazepril in Healthy Chinese Participants.
Journal: Clinical pharmacology in drug development
Published: August 20, 2025
High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects.
Journal: Drug design, development and therapy
Published: February 28, 2025
Bioequivalence Study of Palbociclib Tablets in Healthy Volunteers.
Journal: Drug design, development and therapy
Published: February 17, 2025
Clinical Characteristics and Mechanism Discussion of Peripheral Nerve Injury in 2 Cases of Severe Viral Meningoencephalitis.
Journal: Journal of inflammation research
Published: November 09, 2024
Bioequivalence Study of Single-Pill Capsule Formulation of Amlodipine Plus Benazepril in Healthy Chinese Subjects Under Fasting and Fed Conditions.
Journal: Drug design, development and therapy
Published: October 24, 2024
The effect of high-fat diet on the pharmacokinetics of ondansetron hydrochloride tablets in healthy Chinese subjects.
Journal: Frontiers in pharmacology
Published: October 17, 2024
Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial.
Journal: Frontiers in pharmacology
Published: October 14, 2024
Pharmacokinetics and Bioequivalence of Apremilast Tablets in Chinese Healthy Subjects Under Fasting and Postprandial States.
Journal: Drug design, development and therapy
Published: January 28, 2024
A de novo homozygous missense mutation of the GUSB gene leads to mucopolysaccharidosis type VII identification in a family with twice adverse pregnancy outcomes due to non-immune hydrops fetalis.
Journal: Molecular genetics and metabolism reports
Published: October 17, 2023
Last Updated: 09/26/2026